Related Experiment Video
Updated: Aug 25, 2025

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension
Chen Wang1,2, Yuanming Xing1,2, Jiao Zhang1,2,3
1Department of Cardiology, First Affiliated Hospital of Xi'an Jiaotong University, China (C.W., Y.X., J.Z., J.D., H.W., L.B., J.S., Z.-Y.).
Mediator complex subunit 1 (MED1) and Krüppel-like factor 4 (KLF4) are vital for pulmonary artery health. Their dysregulation impairs bone morphogenetic protein/transforming growth factor-beta signaling, contributing to pulmonary hypertension.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Epigenetics
Background:
- Dysregulated bone morphogenetic protein (BMP) and transforming growth factor-beta (TGF-β) signaling are critical in pulmonary arterial hypertension (PAH).
- MED1 (mediator complex subunit 1) and KLF4 (Krüppel-like factor 4) are key regulators in endothelium, but their roles in PAH pathogenesis are unclear.
- The epigenetic and transcriptional regulation of BMP/TGF-β axes by MED1/KLF4 in pulmonary endothelium leading to PAH requires investigation.
Purpose of the Study:
- To investigate the co-regulation of BMP/TGF-β signaling pathways by MED1 and KLF4 in the pulmonary endothelium.
- To elucidate the epigenetic regulation of BMPR2, ERG, and TGFBR2 by MED1 and KLF4 in the context of pulmonary hypertension (PH).
- To assess the role of MED1 in the development and progression of PH.
Main Methods:
- Utilized high-throughput screening (RNA-seq, ChIP-seq, ATAC-seq, Hi-C) and in silico analyses to explore epigenetic and transcriptional regulation.
- Validated findings using in vitro cultured pulmonary arterial endothelial cells (ECs) and bulk assays.
- Examined lung tissues from PAH patients, PH animal models, and EC-specific MED1 knockout mice (EC-MED1-/-) to evaluate MED1's protective effects.
Main Results:
- MED1 levels were reduced in lung tissues and ECs from PAH patients and PH models.
- MED1 synergistically activated BMPR2, ERG, and TGFBR2 expression with KLF4 through chromatin remodeling and enhancer-promoter interactions.
- Endothelial MED1 ablation led to PH susceptibility, while MED1 overexpression mitigated PH phenotypes in rodents.
Conclusions:
- Homeostatic regulation of BMPR2, ERG, and TGFBR2 by MED1 and KLF4 in ECs is essential for normal pulmonary endothelium function.
- MED1 dysregulation and subsequent impairment of BMP/TGF-β signaling contribute to PAH progression in humans and PH in rodent models.
- MED1 plays a crucial protective role against the development of pulmonary hypertension.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
10:20Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Role of Matrix Metalloproteases in Degradation of ECM
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...